30 results
8-K
EX-10.1
OCX
Oncocyte Corporation
8 Jun 23
Departure of Directors or Certain Officers
6:29pm
disciplinary action, while employed by any former employer that could reasonably be expected to cause any damage to the Company’s business or reputation … on the Company’s business or reputation; (iii) breach of a fiduciary duty or duty of loyalty to the Company or any of its affiliates; (iv) engagement in fraud
8-K
proqjut7 hy1
5 Apr 23
Results of Operations and Financial Condition
9:00am
8-K
EX-10.2
l2r58
21 Dec 22
Oncocyte Announces Initiatives to Focus Corporate Strategy
6:05am
8-K
EX-10.1
5b3xfz4fv4ovw5s
21 Dec 22
Oncocyte Announces Initiatives to Focus Corporate Strategy
6:05am
8-K
EX-2.1
l233n 4k64923wjhv
21 Dec 22
Oncocyte Announces Initiatives to Focus Corporate Strategy
6:05am
8-K
EX-10.4
eva2t7sunsqd
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
kw79yabk
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
w2tflpqzx4j136
7 Oct 21
Oncocyte Appoints Gisela A. Paulsen as Chief Operating Officer
8:05am
8-K
EX-2.1
bvq 2qwg4wwpseeu4pag
19 Apr 21
Entry into a Material Definitive Agreement
1:44pm
424B5
znaph9 fhdgw
8 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
v4a2 mxv4btyh
4 Feb 21
Prospectus supplement for primary offering
4:26pm
8-K
EX-1.01
9dqlz4z1jhhv4qxc
3 Feb 21
Entry into a Material Definitive Agreement
9:07am